BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

292 hedge funds and large institutions have $1.77B invested in BioCryst Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 112 increasing their positions, 84 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
292
Holders Change
+20
Holders Change %
+7.35%
% of All Funds
3.92%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
52
Increased
112
Reduced
84
Closed
30
Calls
$12.7M
Puts
$6.52M
Net Calls
+$6.18M
Net Calls Change
+$1.41M

Top Buyers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
$38.3M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$32.4M
3
UBS Group
UBS Group
Switzerland
$50.3M
4
Morgan Stanley
Morgan Stanley
New York
$47.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
$39.3M

Top Sellers

1
ACA
Avoro Capital Advisors
New York
$40.3M
2
CP
Caligan Partners
New York
$5.72M
3
Millennium Management
Millennium Management
New York
$17.1M
4
Ameriprise
Ameriprise
Minnesota
$960K
5
Alkeon Capital Management
Alkeon Capital Management
New York
$51.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$192M -$12M -1,343,397 -6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$184M -$10M -1,115,517 -5%
State Street
3
State Street
Massachusetts
$76.2M +$6.2M +691,988 +9%
KCM
4
Kynam Capital Management
New Jersey
$75.8M -$4.16M -464,781 -5%
Alkeon Capital Management
5
Alkeon Capital Management
New York
$51.2M -$13.4M -1,500,000 -21%
UBS Group
6
UBS Group
Switzerland
$50.3M +$28.8M +3,211,465 +134%
Morgan Stanley
7
Morgan Stanley
New York
$47.8M +$27.2M +3,032,005 +132%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$45.3M +$842K +93,973 +2%
DM
9
Deerfield Management
New York
$42M -$4.46M -497,665 -10%
ACA
10
Avoro Capital Advisors
New York
$40.3M -$37.6M -4,200,000 -48%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$39.3M +$25.1M +2,800,365 +176%
Two Sigma Investments
12
Two Sigma Investments
New York
$38.4M +$20.1M +2,242,688 +110%
Arrowstreet Capital
13
Arrowstreet Capital
Massachusetts
$38.3M +$36.6M +4,084,403 +2,104%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$37.9M +$9.03M +1,007,700 +31%
Assenagon Asset Management
15
Assenagon Asset Management
Luxembourg
$32.4M +$32.3M +3,606,566 +25,631%
NL
16
Nuveen LLC
North Carolina
$31.7M +$18.9M +2,110,808 +148%
Goldman Sachs
17
Goldman Sachs
New York
$31.6M +$14.3M +1,591,983 +82%
Bank of America
18
Bank of America
North Carolina
$25.5M +$12.6M +1,405,498 +98%
Fisher Asset Management
19
Fisher Asset Management
Washington
$24.9M -$2.42M -269,648 -9%
GKIM
20
GW&K Investment Management
Massachusetts
$23.5M -$2.34M -261,143 -9%
Citadel Advisors
21
Citadel Advisors
Florida
$22.9M +$17.8M +1,983,243 +345%
Renaissance Technologies
22
Renaissance Technologies
New York
$22.6M +$17.2M +1,921,516 +317%
Voloridge Investment Management
23
Voloridge Investment Management
Florida
$22.2M +$3.95M +440,292 +22%
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$21.3M +$12.8M +1,432,824 +152%
Walleye Capital
25
Walleye Capital
New York
$20.6M +$19.2M +2,145,936 +1,387%
1
2 3 4 5